Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Liver Diseases

Free Subscription 29.11.2021 2 AJR Am J Roentgenol 2 Am J Gastroenterol 2 Biochem Biophys Res Commun 1 BMC Cancer 2 BMC Gastroenterol 1 Clin Res Hepatol Gastroenterol 5 Dig Dis 2 Dig Dis Sci 1 Endoscopy 1 Gastroenterology 1 Gastrointest Endosc 1 Gut 2 Hepatology 1 J Clin Oncol 1 J Gastroenterol Hepatol 7 J Hepatol 2 J Pediatr 13 PLoS One 1 Pol J Radiol 1 Radiol Imaging Cancer 22 Semin Liver Dis 5 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. GUO Z, Blake GM, Graffy PM, Sandfort V, et al
   Hepatic Steatosis: CT-based Prevalence in Adults in China and the United States and Associations with Age, Sex, and Body Mass Index.
   AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26728.
   PubMed         Abstract available
   
   
2. RONG D, He B, Tang W, Xie S, et al
   Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.
   AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26818.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

3. REIG A, Alvarez-Navascues C, Vergara M, Gomez-Dominguez E, et al
   Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
   Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00017.
   PubMed         Abstract available
   
   
4. KIM Y, Chang Y, Kwon MJ, Hong YS, et al
   Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
   Am J Gastroenterol. 2021;116:2270-2278.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

5. SZTOLSZTENER K, Harasim-Symbor E, Chabowski A, Konstantynowicz-Nowicka K, et al
   The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate.
   Biochem Biophys Res Commun. 2021;585:132-138.
   PubMed         Abstract available
   
   
6. JIN Y, Yang R, Ding J, Zhu F, et al
   KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP.
   Biochem Biophys Res Commun. 2021;585:185-190.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. WANG C, Jiang X, Huang B, Zhou W, et al
   Inhibition of matrix stiffness relating integrin beta1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts.
   BMC Cancer. 2021;21:1276.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

8. AKUTA N, Kawamura Y, Arase Y, Saitoh S, et al
   PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD.
   BMC Gastroenterol. 2021;21:434.
   PubMed         Abstract available
   
   
9. SIMON TG, Hagstrom H, Sharma R, Soderling J, et al
   Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.
   BMC Gastroenterol. 2021;21:439.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

10. MOREIRA JLS, Barbosa SMB, Goncalves Junior J
    Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review.
    Clin Res Hepatol Gastroenterol. 2021;45:101752.
    PubMed         Abstract available
    
    

    
    Dig Dis

11. SHAO X, Uojima H, Arai T, Ogawa Y, et al
    The risk of cirrhosis and its complications based on PNPLA3 rs738409 G allele frequency.
    Dig Dis. 2021 Nov 22. pii: 000521062. doi: 10.1159/000521062.
    PubMed         Abstract available
    
    
12. ATTA S, Kamel M, Mansour W, Hussein T, et al
    Ascitic Fluid Cytokines in Chronic Liver Disease: A Possible Prognostic Tool.
    Dig Dis. 2021;39:534-539.
    PubMed         Abstract available
    
    
13. FREITAS M, Macedo Silva V, Xavier S, Magalhaes J, et al
    Early Kidney Dysfunction in Metabolic-Associated Fatty Liver Disease: Is Transient Elastography Useful as a Screening Method?
    Dig Dis. 2021;39:653-662.
    PubMed         Abstract available
    
    
14. YAMAMOTO K, Ikeya T, Okuyama S, Fukuda K, et al
    Association between the Frequency of Daily Toothbrushing and Development of Nonalcoholic Fatty Liver Disease.
    Dig Dis. 2021;39:646-652.
    PubMed         Abstract available
    
    
15. PARK J, Lee EY, Li J, Jun MJ, et al
    NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.
    Dig Dis. 2021;39:634-645.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

16. CHANG JI, Sinn DH, Cho H, Kim S, et al
    Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07312.
    PubMed         Abstract available
    
    
17. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
    Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
    PubMed         Abstract available
    
    

    
    Endoscopy

18. OKAMOTO T, Nakamura K, Yabuta M, Fukuda K, et al
    Correction: Retrograde endosonography-guided hepaticojejunostomy after failed rendezvous in a patient with Roux-en-Y anastomosis.
    Endoscopy. 2021 Nov 24. doi: 10.1055/a-1634-1768.
    PubMed        
    
    

    
    Gastroenterology

19. LOOMBA R, Ratziu V, Harrison SA
    Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2021 Nov 22. pii: S0016-5085(21)03795.
    PubMed        
    
    

    
    Gastrointest Endosc

20. KOLB JM, Samarasena JB
    EUS-guided splenic artery embolization for variceal hemorrhage: balancing creativity and innovation in Endo-hepatology with caution.
    Gastrointest Endosc. 2021 Nov 18. pii: S0016-5107(21)01647.
    PubMed        
    
    

    
    Gut

21. LIU DS, Frampton AE
    Plasma extracellular vesicles contain unannotated small RNA clusters suitable as biomarkers for detecting early hepatocellular carcinoma.
    Gut. 2021 Nov 19. pii: gutjnl-2021-325798. doi: 10.1136/gutjnl-2021-325798.
    PubMed        
    
    

    
    Hepatology

22. GHANY MG, King WC, Lisker-Melman M, Sf Lok A, et al
    Letter to the Editor: HBcrAg and Prediction of Hepatocellular Carcinoma Risk.
    Hepatology. 2021 Nov 20. doi: 10.1002/hep.32251.
    PubMed         Abstract available
    
    
23. JAIN A, Sharma BC, Mahajan B, Srivastava S, et al
    "L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial".
    Hepatology. 2021 Nov 25. doi: 10.1002/hep.32255.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

24. RAYSON D
    Cardio-Oncology.
    J Clin Oncol. 2021;39:2962-2963.
    PubMed        
    
    

    
    J Gastroenterol Hepatol

25. GAZELAKIS K, Mendis S, Wang S, Wong S, et al
    Hepatobiliary and Pancreatic: Liver lesions in cirrhosis: When to biopsy?
    J Gastroenterol Hepatol. 2021 Nov 22. doi: 10.1111/jgh.15735.
    PubMed        
    
    

    
    J Hepatol

26. FISCHER P, Stefanescu H, Hategan R, Procopet B, et al
    Bacterial infection-related acute-on-chronic liver failure: The standpoint matters!
    J Hepatol. 2021;75:1009-1010.
    PubMed        
    
    
27. LIN S, Agarwal B, Kumar R, Jalan R, et al
    Defining the prognosis of critically ill patients with alcohol-related liver disease.
    J Hepatol. 2021;75:986-987.
    PubMed        
    
    
28. RUDLER M, Savier E, Alioua I, Sultanik P, et al
    TIPS and liver transplantation should always be discussed together.
    J Hepatol. 2021 May 26. pii: S0168-8278(21)00347.
    PubMed        
    
    
29. FENG MW, Hanley KL, Feng GS
    Androgen receptor, neovascularization and liver cancer metastasis.
    J Hepatol. 2021;75:768-769.
    PubMed        
    
    
30. BETTINGER D, Thimme R, Schultheiss M
    Reply: TIPS and liver transplantation should always be discussed together.
    J Hepatol. 2021 Jul 6. pii: S0168-8278(21)01891.
    PubMed        
    
    
31. WONG F, Piano S, Angeli P
    Reply to: Correspondence on "Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure".
    J Hepatol. 2021;75:1010-1012.
    PubMed        
    
    
32. XU X, Nan Y
    Reply to: Correspondence on "The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease".
    J Hepatol. 2021 Nov 11. pii: S0168-8278(21)02170.
    PubMed        
    
    

    
    J Pediatr

33. HEGARTY R, Gibson P, Sambrotta M, Strautnieks S, et al
    Study of Acute Liver Failure in Children Using Next Generation Sequencing Technology.
    J Pediatr. 2021;236:124-130.
    PubMed         Abstract available
    
    
34. AL-HUSSAINI A, Lone K, Bashir MS, Alrashidi S, et al
    ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations associated with cholestasis with Different phenotypes and Outcomes.
    J Pediatr. 2021 Apr 26. pii: S0022-3476(21)00391.
    PubMed         Abstract available
    
    

    
    PLoS One

35. YANG CJ, Wang CK, Fang YD, Wang JY, et al
    Clinical application of mask region-based convolutional neural network for the automatic detection and segmentation of abnormal liver density based on hepatocellular carcinoma computed tomography datasets.
    PLoS One. 2021;16:e0255605.
    PubMed         Abstract available
    
    
36. ZHOU J, Zhu Y, Ma S, Li Y, et al
    Bioinformatics analysis identifies DYNC1I1 as prognosis marker in male patients with liver hepatocellular carcinoma.
    PLoS One. 2021;16:e0258797.
    PubMed         Abstract available
    
    
37. XIE Y, Liu C, Zhang Y, Li A, et al
    PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair.
    PLoS One. 2021;16:e0258817.
    PubMed         Abstract available
    
    
38. HSU PK, Wu LS, Su WW, Su PY, et al
    Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis.
    PLoS One. 2021;16:e0254892.
    PubMed         Abstract available
    
    
39. WANG Y, Xiao X, Wang X, Guo F, et al
    Identification of differentially expressed long noncoding RNAs and pathways in liver tissues from rats with hepatic fibrosis.
    PLoS One. 2021;16:e0258194.
    PubMed         Abstract available
    
    
40. KHAMIS ZI, Pang X, Cui Z, Sang QA, et al
    Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity.
    PLoS One. 2021;16:e0257072.
    PubMed         Abstract available
    
    
41. CHUAYPEN N, Limothai U, Kunadirek P, Kaewsapsak P, et al
    Identification and validation of circulating miRNAs as potential new biomarkers for severe liver disease in patients with leptospirosis.
    PLoS One. 2021;16:e0257805.
    PubMed         Abstract available
    
    
42. PARK JH, Chung YE, Seo N, Choi JY, et al
    Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations.
    PLoS One. 2021;16:e0257308.
    PubMed         Abstract available
    
    
43. LI M, Hu M, Yue Z, Zhang Y, et al
    The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.
    PLoS One. 2021;16:e0257391.
    PubMed         Abstract available
    
    
44. BHATT SP, Guleria R
    Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians.
    PLoS One. 2021;16:e0245408.
    PubMed         Abstract available
    
    
45. HUNOLD P, Berg T, Seehofer D, Sucher R, et al
    Experiences from six years of quality assured Model of End Stage Liver Disease (MELD) diagnostics.
    PLoS One. 2021;16:e0254219.
    PubMed         Abstract available
    
    
46. MINICOZZI MR, Axlid EG, von Hippel FA, Espinoza J, et al
    Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish.
    PLoS One. 2021;16:e0254500.
    PubMed         Abstract available
    
    
47. ISOURA Y, Yamamoto A, Cho Y, Ehara E, et al
    Platelet count and abdominal dynamic CT are useful in predicting and screening for gastroesophageal varices after Fontan surgery.
    PLoS One. 2021;16:e0257441.
    PubMed         Abstract available
    
    

    
    Pol J Radiol

48. MORAD K, Moustafa AF, Refaat AM, AbdEllatif A, et al
    Optimizing diagnostic imaging data using LI-RADS and the Likert scale in patients with hepatocellular carcinoma.
    Pol J Radiol. 2021;86:e557-e563.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

49. CHANDRA VM
    Residual Tumor Perfusion Predicts Outcome from Chemoembolization of Hepatocellular Carcinoma.
    Radiol Imaging Cancer. 2021;3:e219024.
    PubMed        
    
    

    
    Semin Liver Dis

50. MENDOZA YP, Becchetti C, Watt KD, Berzigotti A, et al
    Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases.
    Semin Liver Dis. 2021;41:448-460.
    PubMed         Abstract available
    
    
51. MAIWALL R, Sarin SK
    Plasma Exchange in Acute and Acute on Chronic Liver Failure.
    Semin Liver Dis. 2021;41:476-494.
    PubMed         Abstract available
    
    
52. HASHEM A, Khalouf A, Acosta A
    Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review.
    Semin Liver Dis. 2021;41:435-447.
    PubMed         Abstract available
    
    
53. GU X, Lu Q, Zhang C, Tang Z, et al
    Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review.
    Semin Liver Dis. 2021;41:495-506.
    PubMed         Abstract available
    
    
54. KOHUT TJ, Gilbert MA, Loomes KM
    Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment.
    Semin Liver Dis. 2021;41:525-537.
    PubMed         Abstract available
    
    
55. KAWAGUCHI T, Charlton M, Kawaguchi A, Yamamura S, et al
    Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
    Semin Liver Dis. 2021;41:225-234.
    PubMed         Abstract available
    
    
56. SHERMAN M
    Assessing Toxicity in Drug Trials in Liver Disease.
    Semin Liver Dis. 2021;41:277-284.
    PubMed         Abstract available
    
    
57. TELLEZ L, Rodriguez de Santiago E, Albillos A
    Fontan-Associated Liver Disease: Pathophysiology, Staging, and Management.
    Semin Liver Dis. 2021;41:538-550.
    PubMed         Abstract available
    
    
58. ARRESE M, Arab JP, Barrera F, Kaufmann B, et al
    Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity.
    Semin Liver Dis. 2021;41:421-434.
    PubMed         Abstract available
    
    
59. NILLES KM, Levitsky J
    Current and Evolving Indications for Simultaneous Liver Kidney Transplantation.
    Semin Liver Dis. 2021;41:308-320.
    PubMed         Abstract available
    
    
60. ZELBER-SAGI S
    Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations.
    Semin Liver Dis. 2021;41:248-262.
    PubMed         Abstract available
    
    
61. MA L, Khatib S, Craig AJ, Wang XW, et al
    Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution.
    Semin Liver Dis. 2021;41:321-330.
    PubMed         Abstract available
    
    
62. LI N, Yamamoto G, Fuji H, Kisseleva T, et al
    Interleukin-17 in Liver Disease Pathogenesis.
    Semin Liver Dis. 2021;41:507-515.
    PubMed         Abstract available
    
    
63. GIL-GOMEZ A, Brescia P, Rescigno M, Romero-Gomez M, et al
    Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers.
    Semin Liver Dis. 2021;41:191-205.
    PubMed         Abstract available
    
    
64. MOLLER S, Kimer N, Kronborg T, Grandt J, et al
    Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms.
    Semin Liver Dis. 2021;41:235-247.
    PubMed         Abstract available
    
    
65. ENGELMANN C, Martino VD, Kerbert AJC, Weil-Verhoeven D, et al
    The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2021;41:298-307.
    PubMed         Abstract available
    
    
66. ORTIZ V, Ellenberg SS, Weinberg EM
    Blinding in Clinical Trials for Chronic Liver Diseases.
    Semin Liver Dis. 2021;41:163-171.
    PubMed         Abstract available
    
    
67. HARTMANN P, Schnabl B
    New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease.
    Semin Liver Dis. 2021;41:87-102.
    PubMed         Abstract available
    
    
68. DUNN MA, Kappus MR, Bloomer PM, Duarte-Rojo A, et al
    Wearables, Physical Activity, and Exercise Testing in Liver Disease.
    Semin Liver Dis. 2021;41:128-135.
    PubMed         Abstract available
    
    
69. FERREIRA-GONZALEZ S, Rodrigo-Torres D, Gadd VL, Forbes SJ, et al
    Cellular Senescence in Liver Disease and Regeneration.
    Semin Liver Dis. 2021;41:50-66.
    PubMed         Abstract available
    
    
70. WANG H, Calvisi DF, Chen X
    Organoids for the Study of Liver Cancer.
    Semin Liver Dis. 2021;41:19-27.
    PubMed         Abstract available
    
    
71. RADUN R, Trauner M
    Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities.
    Semin Liver Dis. 2021;41:461-475.
    PubMed         Abstract available
    
    

    
    Transplant Proc

72. KUBO M, Gotoh K, Kobayashi S, Iwagami Y, et al
    Modified Cavoportal Hemitransposition for Severe Portal Vein Thrombosis Contributed to Long-term Survival After Deceased Donor Liver Transplantation-Insight Into Portal Modulation for Improving Survival: A Case Report.
    Transplant Proc. 2021 Jul 9. pii: S0041-1345(21)00445.
    PubMed         Abstract available
    
    
73. BELL PT, Carew A, Fiene A, Divithotawela C, et al
    Combined Heart-Lung-Liver Transplantation for Patients With Cystic Fibrosis: The Australian Experience.
    Transplant Proc. 2021 Aug 16. pii: S0041-1345(21)00518.
    PubMed         Abstract available
    
    
74. JUSTO I, Marcacuzco A, Caso O, Garcia-Conde M, et al
    Hemoderivative Transfusion in Liver Transplantation: Comparison Between Recipients of Grafts From Brain Death Donors and Recipients of Uncontrolled Donors After Circulatory Death.
    Transplant Proc. 2021 Aug 19. pii: S0041-1345(21)00494.
    PubMed         Abstract available
    
    
75. NOVRUZOV N, Ersan V, Bayramov N, Otlu B, et al
    Extracellular Histones H3 as a Prognostic Blood Marker for Delayed Liver Function Recovery After Donor Hepatectomy.
    Transplant Proc. 2021;53:2305-2311.
    PubMed         Abstract available
    
    
76. KARATAS C, Alim A, Tirnova I, Demir B, et al
    Patient With Hemophilia A Undergoing Consecutive Coronary Bypass and Live Donor Liver Transplantation: A Case Report.
    Transplant Proc. 2021 Sep 13. pii: S0041-1345(21)00548.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: